267 related articles for article (PubMed ID: 19841376)
1. Teaching NeuroImages: reversible ectropion in myasthenia gravis.
Solé G; Perez F; Ferrer X
Neurology; 2009 Oct; 73(16):e83. PubMed ID: 19841376
[No Abstract] [Full Text] [Related]
2. Teaching neuroimages: reversible ectropion in myasthenia gravis.
Chang GY; Solé G; Ferrer X
Neurology; 2010 Apr; 74(15):1239; author reply 1239. PubMed ID: 20385900
[No Abstract] [Full Text] [Related]
3. [Current treatment of myasthenia gravis].
de Assis JL
Rev Paul Med; 1965 Oct; 67(4):231-42. PubMed ID: 5848156
[No Abstract] [Full Text] [Related]
4. Post-varicella myasthenia gravis.
Saha A; Batra P; Vilhekar KY; Chaturvedi P
Singapore Med J; 2007 Jun; 48(6):e177-80. PubMed ID: 17538742
[TBL] [Abstract][Full Text] [Related]
5. Myasthenia gravis: a real emergency.
Kutzin JM
Int Emerg Nurs; 2012 Apr; 20(2):102-5. PubMed ID: 22483007
[No Abstract] [Full Text] [Related]
6. A cause of reversible dysphagia: an unusual presentation of myasthenia gravis.
Brostoff JM; Dahdaleh D; Birns J
Eur J Intern Med; 2008 Jan; 19(1):70. PubMed ID: 18206608
[No Abstract] [Full Text] [Related]
7. Myasthenia gravis and glycopyrrolate.
Marcus E; Wayne F
S Afr Med J; 1981 Oct; 60(17):650. PubMed ID: 7302713
[No Abstract] [Full Text] [Related]
8. [Myasthenia gravis pseudoparalytica. Clinical picture, pathogenesis, therapy].
Kunze K
Med Klin; 1973 Jun; 68(22):723-30. PubMed ID: 4715780
[No Abstract] [Full Text] [Related]
9. Treatment of myasthenia. II.
Br Med J; 1971 Apr; 2(5755):213-4. PubMed ID: 5575956
[No Abstract] [Full Text] [Related]
10. [Therapetic measures in myasthenia gravis].
Cavaciuti P; Gatti E
Minerva Anestesiol; 1969 Aug; 35(8):765-79. PubMed ID: 5364124
[No Abstract] [Full Text] [Related]
11. Treatment of myasthenia--I.
Br Med J; 1971 Apr; 2(5754):160-2. PubMed ID: 4325739
[No Abstract] [Full Text] [Related]
12. Diseases of the central nervous system. Myasthenia gravis.
Havard CW
Br Med J; 1975 Oct; 4(5989):152-4. PubMed ID: 1191974
[No Abstract] [Full Text] [Related]
13. [A curable muscular disease].
Oosterhuis HJ
Ned Tijdschr Geneeskd; 1976 Jan; 120(5):181-4. PubMed ID: 1250450
[No Abstract] [Full Text] [Related]
14. Myasthenia gravis and masticatory muscle myositis in a dog.
Clooten JK; Woods JP; Smith-Maxie LL
Can Vet J; 2003 Jun; 44(6):480-3. PubMed ID: 12839242
[TBL] [Abstract][Full Text] [Related]
15. An unusual presentation of myasthenia gravis.
Chijoke A; Ogunmodele JA
West Afr J Med; 2009; 28(6):391-3. PubMed ID: 20486100
[TBL] [Abstract][Full Text] [Related]
16. Early onset myasthenia gravis with atypical features.
Agarwal P; Chapagain U; Deewan KR; Rana PV
Kathmandu Univ Med J (KUMJ); 2008; 6(2):231-4. PubMed ID: 18769095
[TBL] [Abstract][Full Text] [Related]
17. The effect of use of pyridostigmine and requirement of vecuronium in patients with myasthenia gravis.
Tripathi M; Kaushik S; Dubey P
J Postgrad Med; 2003; 49(4):311-4; discussion 314-5. PubMed ID: 14699228
[TBL] [Abstract][Full Text] [Related]
18. [Myasthenia gravis in an active 48-year-old woman, demonstrated clinically, electrically and serologically, well tolerated for 30 years, thanks to Prostigmine and Mestinon. Some theoretical and practical problems].
Chesni Y
Rev Med Suisse Romande; 1979 May; 99(5):289-90. PubMed ID: 119291
[No Abstract] [Full Text] [Related]
19. Cholinesterase inhibitors in myasthenia gravis.
Lange MJ
Practitioner; 1966 Mar; 196(173):448-53. PubMed ID: 5905423
[No Abstract] [Full Text] [Related]
20. Myasthenia gravis in a one year eight months old female child.
Karmakar BC; Sinhamahapatra TK; Mallick AK; Das GC
J Indian Med Assoc; 2011 Aug; 109(8):595. PubMed ID: 22315873
[No Abstract] [Full Text] [Related]
[Next] [New Search]
